title: Asparaginase use for the treatment of acute lymphoblastic leukemia.
authors.affiliation: Servicio de Hematología, Hospital Universitari Vall d'Hebrón, Universidad Autònoma de Barcelona, Barcelona, España. Electronic address: pebarba@vhebron.net.
authors.forename: Pere
authors.initials: P
authors.lastname: Barba
authors.affiliation: Servicio de Oncología y Hematología pediátricas, Hospital Universitari Vall d'Hebrón, Barcelona, España.
authors.forename: José Luis
authors.initials: JL
authors.lastname: Dapena
authors.affiliation: Hospital Universitari i Politècnic la Fe, València, España.
authors.forename: Pau
authors.initials: P
authors.lastname: Montesinos
authors.affiliation: Hospital Universitari Sant Joan de Déu, Barcelona, España.
authors.forename: Susana
authors.initials: S
authors.lastname: Rives
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001215:Asparaginase / Q000009:adverse effects / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D016903:Drug Monitoring; D006801:Humans; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D001215:Asparaginase